Biotech Acquisition in Liver Disease and Weight-Loss Drugs Roche acquires 89bio for $3.5B. Focus on liver disease treatments. Complements weight-loss drug research Pharmaceuticals | Biotech Acquisition | Healthcare Innovations United States 4 months ago